CGON
Financials
- Market Capitalization 6.59 B
- Employee 142
- Founded 2010
- CEO N/A
- Website www.cgoncology.com
- Headquarter Delaware, United States
- FIGI BBG00YHKK4Q3
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 377 |  ONC BeOne Medicines Ltd - American Depositary Shares | 366.73 USD | -1.55% | -0.82% | +13.19% | +16.16% | 41.70 B USD | ||
| 440 |  BIIB Biogen Inc. - Common Stock | 218.50 USD | -1.35% | +0.97% | +6.91% | +63.61% | 32.28 B USD | ||
| 1219 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 91.15 USD | -5.58% | -14.61% | +0.92% | +184.22% | 6.04 B USD | ||
| 1497 |  MANE Veradermics, Incorporated Common Stock | 97.84 USD | -3.69% | -4.65% | -10.11% | +196.48% | 4.09 B USD |
Frequently asked questions about CG Oncology, Inc. Common stock
What is the CG Oncology, Inc. Common stock stock price today?
The current price of CG Oncology, Inc. Common stock (CGON) is 74.34. Over the past 24 hours, the stock has changed by -5.91%. Follow the CGON chart for real-time price dynamics.
What is the stock ticker of CG Oncology, Inc. Common stock?
CG Oncology, Inc. Common stock trades under the ticker CGON. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CG Oncology, Inc. Common stock stock going up?
CGON has changed by -6.42% over the last week, +7.40% over the last month, and +70.66% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of CG Oncology, Inc. Common stock?
CG Oncology, Inc. Common stock currently has a market capitalization of 6.59 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were CG Oncology, Inc. Common stock earnings last quarter?
Last quarter, CG Oncology, Inc. Common stock reported earnings of -0.9 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was CG Oncology, Inc. Common stock revenue for the last quarter?
CG Oncology, Inc. Common stock reported quarterly revenue of 1.16 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was CG Oncology, Inc. Common stock net income for the last quarter?
CG Oncology, Inc. Common stock reported net income of -79.06 M for the last quarter. The previous quarter showed -60.2 M, which means net income changed by -31.32%.
How many employees does CG Oncology, Inc. Common stock have?
As of the latest available data, CG Oncology, Inc. Common stock has 142 employees. Workforce size can provide additional context about the company's scale and operations.
What is CG Oncology, Inc. Common stock EBITDA?
CG Oncology, Inc. Common stock EBITDA is -114.53 M, and its EBITDA margin is -9 898.62%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy CG Oncology, Inc. Common stock stock?
You can buy CG Oncology, Inc. Common stock (CGON) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CG Oncology, Inc. Common stock stock?
Investing in CG Oncology, Inc. Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CGON chart and related analysis on metatrader.com as part of your research.